Browsing by Author GIESEL FREDERIK

Showing results 1 to 14 of 14
Publication YearJRC N°TitleAuthor(s), Editor(s), Other Contributor(s)Publication Type
2017JRC106148225Ac-PSMA617: PSMA targeting alpha-radiation therapy of patients with mCRPCKRATOCHWIL CLEMENS; BRUCHERTSEIFER FRANK; GIESEL FREDERIK; APOSTOLIDIS CHRISTOS; HABERKORN UWE; MORGENSTERN ALFREDArticles in periodicals and books
2017JRC105920The Future of Radioligand Therapy: α, β, or Both?HABERKORN UWE; GIESEL FREDERIK; MORGENSTERN ALFRED; KRATOCHWIL CLEMENSArticles in periodicals and books
2019JRC112045Initial clinical experience performing sialendoscopy for salivary gland protection in patients undergoing 225Ac-PSMA-617 RLTRATHKE H; KRATOCHWIL CLEMENS; HOHENBERG RALPH; GIESEL FREDERIK; BRUCHERTSEIFER FRANK; FLECHSIG PAUL; MORGENSTERN ALFRED; HEIN MATTI; PLINKERT PETER; HABERKORN UWE, et alArticles in periodicals and books
2018JRC113296Initial clinical experience performing sialendoscopy for salivary glands protection for patients under 225Ac-PSMA-617-RLTRATHKE H; KRATOCHWIL CLEMENS; HOHENBERGER R; GIESEL FREDERIK; BRUCHERTSEIFER FRANK; FLECHSIG PAUL; MORGENSTERN ALFRED; PLINKERT PETER; HABERKORN UWE; BULUT OLCAY CEMArticles in periodicals and books
2018JRC110544Initial experience with 225Ac-PSMA-617 in patients with advanced-stage prostate cancerSATHEKGE MIKE; KNOESEN OTTO; BRUCHERTSEIFER FRANK; REYNEKE F; KRATOCHWIL CLEMENS; LENGANA T; GIESEL FREDERIK; LAWAL I; BOSHOMANE T; VORSTER MARIZA, et alArticles in periodicals and books
2018JRC111747Optimizing the treatment regimen for targeted alpha therapy of mCRPC with 225Ac-PSMA-617KRATOCHWIL CLEMENS; RATHKE H; BRUCHERTSEIFER FRANK; GIESEL FREDERIK; HABERKORN UWE; MORGENSTERN ALFREDArticles in periodicals and books
2019JRC117534Optimizing the treatment regimen for targeted alpha therapy of mCRPC with Ac-PSMA-617BRUCHERTSEIFER FRANK; KRATOCHWIL CLEMENS; RATHKE H; HABERKORN UWE; MORGENSTERN ALFRED; GIESEL FREDERIKArticles in periodicals and books
2017JRC106777PSMA-targeting alpha-Radiation therapy with 225Actinium-PSMA-617: Dosimetry, toxicity and duration of tumor-controlKRATOCHWIL CLEMENS; BRUCHERTSEIFER FRANK; GIESEL FREDERIK; APOSTOLIDIS CHRISTOS; HABERKORN UWE; MORGENSTERN ALFREDArticles in periodicals and books
2019JRC113787Resistance against PSMA-targeting alpha-radiation therapy coincides with mutations in DNA-repair associated genesKRATOCHWIL CLEMENS; HEUSSEL C.P.; BRUCHERTSEIFER FRANK; HABERKORN UWE; MORGENSTERN ALFRED; STENZINGER A; DUENSING S; GIESEL FREDERIKArticles in periodicals and books
2018JRC110543Targeted Alpha Therapy of mCRPC with 225Actinium-PSMA617: Dosimetry, toxicity and duration of tumor-controlBRUCHERTSEIFER FRANK; MORGENSTERN ALFRED; GIESEL FREDERIK; APOSTOLIDIS CHRISTOS; HABERKORN UWE; KRATOCHWIL CLEMENSArticles in periodicals and books
2017JRC106723Targeted Alpha Therapy of mCRPC: Dosimetry estimate of 213Bismuth-PSMA-617KRATOCHWIL CLEMENS; SCHMIDT K.; BRUCHERTSEIFER FRANK; AFSHAR-OROMIEH ALI; MORGENSTERN ALFRED; HABERKORN UWE; GIESEL FREDERIKArticles in periodicals and books
2018JRC107359Targeted alpha therapy of mCRPC: Dosimetry estimate of 213Bismuth-PSMA-617KRATOCHWIL CLEMENS; SCHMIDT K.; AFSHAR-OROMIEH ALI; BRUCHERTSEIFER FRANK; RATHKE H; MORGENSTERN ALFRED; HABERKORN UWE; GIESEL FREDERIKArticles in periodicals and books
2017JRC105916Targeted α-Therapy of Metastatic Castration-Resistant Prostate Cancer with 225Ac-PSMA-617: Dosimetry Estimate and Empiric Dose FindingKRATOCHWIL CLEMENS; BRUCHERTSEIFER FRANK; RATHKE H; BRONZEL M; APOSTOLIDIS CHRISTOS; WEICHERT W; HABERKORN UWE; GIESEL FREDERIK; MORGENSTERN ALFREDArticles in periodicals and books
2018JRC108511Targeted α-Therapy of Metastatic Castration-Resistant Prostate Cancer with 225Ac-PSMA-617: Swimmer-Plot Analysis Suggests Efficacy Regarding Duration of Tumor ControlKRATOCHWIL CLEMENS; BRUCHERTSEIFER FRANK; RATHKE H; HOHENFELLNER MARKUS; GIESEL FREDERIK; HABERKORN UWE; MORGENSTERN ALFREDArticles in periodicals and books